LYON, France, April 22, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today the launch of a follow-on public offering of its American Depositary Shares, or ADSs, each representing one ordinary share of the Company.
Generated record fourth quarter revenue of EUR 15.4 million ( USD 18.3 million ), an increase of 28% year-over-year; HIFU revenue up 51% year-over-year Generated €41.7 million revenue and profitable operating result for the full year 2020. Completed sales to renowned healthcare institutions, such
Company to host conference call and webcast on Wednesday, March 31 at 8:30 am EDT LYON, France , March 23, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and year ended
Initiatives focused on making HIFU procedures broadly accessible to both Medicare and commercially insured patients LYON, France , March 3, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announces today that the company has selected
Record HIFU revenue growth of 50% in the fourth quarter 2020 driven by the sale of eight HIFU devices sold during the quarter Achieved sequential quarterly revenue growth throughout 2020 notwithstanding challenges posed by the ongoing COVID-19 pandemic Company to announce fourth quarter and full
LYON, France , January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski , President and CEO, will participate in a fireside chat at the B. Riley Securities Virtual Oncology Investor Conference on
Results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP) HIFU treatment also resulted in meaningful benefits in both urinary and erectile function versus RP showing superior quality of life preservation capability LYON, France ,
Recaps progress made in 2020 notwithstanding the ongoing COVID-19 pandemic and previews anticipated 2021 milestones LYON, France , January 6, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders:
LYON, France , January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that it will participate in the 10 th Annual LifeSci Partners Corporate Access Event, January 6-8 and 11-14, 2021.
Among December deals closed, two major US institutions have purchased Focal On University of California, San Francisco Medical Center and Cleveland Clinic become latest to adopt Focal One high intensity focused ultrasound (HIFU) technology Sales include a bundled sale with ExactVuTM as well as
